Mergers and Acquisitions - Strive (ASST) entered into a definitive agreement to acquire Semler Scientific (SMLR) in an all-stock transaction [1] - Semler Scientific's Eric Semler to join Strive board post close [1] Bitcoin Holdings - Strive announced the purchase of 5,816 Bitcoin [1] - The combined company will hold more than 10,900 Bitcoin [1] Business Strategy - Post-merger intention to monetize or distribute Semler Scientific's historically profitable diagnostics business [1]

Core Viewpoint - Strive, Inc. has entered into a definitive agreement to acquire Semler Scientific, Inc. in an all-stock transaction, enhancing its position as a leading Bitcoin treasury company and expanding its business into medical diagnostics [1][2]. Company Overview - Strive, Inc. is the first publicly traded asset management Bitcoin treasury company, currently holding 5,886 Bitcoin and managing over $2 billion in assets since launching its first ETF in August 2022 [4]. - Semler Scientific, Inc. is a leader in medical devices and software aimed at combating chronic diseases and is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset [6][7]. Transaction Details - The acquisition represents an approximately 210% premium, equivalent to about $90.52 per share, based on the trading prices as of September 19, 2025 [6]. - Each common share of Semler Scientific will be exchanged for 21.05 Class A common shares of Strive [6]. - The combined company will own over 10,900 Bitcoin prior to any additional Bitcoin raised from future financings [6]. Strategic Goals - The merger aims to create significant value for stockholders by delivering a substantial premium and expanding into a robust preventative care and wellness platform focused on early detection of chronic diseases [2][6]. - Strive's management intends to operate with a "preferred equity only" leverage model to avoid debt maturity risks associated with traditional leveraged Bitcoin strategies [6]. Legal and Financial Advisory - Davis Polk & Wardwell LLP is serving as legal counsel to Strive, while Goodwin Procter LLP is legal counsel to Semler Scientific [3]. - Cantor Fitzgerald, L.P. is the financial advisor to Strive, and LionTree Advisors LLC is the financial advisor to Semler Scientific [3].

Group 1 - The law firm Faruqi & Faruqi, LLP is investigating potential claims against Semler Scientific, Inc. and has set a deadline of October 28, 2025, for investors to seek the role of lead plaintiff in a federal securities class action [2][4] - The complaint alleges that Semler Scientific and its executives violated federal securities laws by making false or misleading statements and failing to disclose a material investigation by the U.S. Department of Justice regarding violations of the False Claims Act [4][5] - Following the disclosure of initial settlement discussions with the DOJ, Semler Scientific's stock fell over 9% on the next trading day, indicating a significant market reaction to the news [5] Group 2 - Investors who suffered losses exceeding $75,000 in Semler Scientific between March 10, 2021, and April 15, 2025, are encouraged to contact the law firm to discuss their legal rights [1][7] - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995, highlighting its experience and capability in handling securities litigation [3]

Core Viewpoint - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, while discussing potential violations in hypothetical terms [2]. - As a result of these actions, the public statements made by the defendants were materially false and misleading throughout the relevant period [2]. Group 2: Next Steps for Investors - Investors who experienced losses in Semler Scientific during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be eligible for compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4].

Accessibility StatementSkip Navigation NEW YORK, Sept. 19, 2025 /PRNewswire/ -- Levi &Â Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Semler Scientific, Inc. investors who were adversely affected by alleged securities fraud between March 10, 2021 and April 15, 2025. Follow the link below to get more information and be contacted by ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Semler Scientific, Inc. due to allegations of violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by October 28, 2025 [2][4]. Group 1: Legal Investigation - The investigation focuses on claims that Semler Scientific and its executives made false or misleading statements and failed to disclose a material investigation by the U.S. Department of Justice regarding violations of the False Claims Act [4]. - The company disclosed in its 2024 annual report that it began initial settlement discussions with the DOJ on February 11, 2025, but ceased those discussions the same day, indicating a risk of a civil lawsuit [5]. Group 2: Financial Impact - Following the disclosure of the DOJ investigation and the cessation of settlement discussions, Semler Scientific's stock price fell over 9% on the next trading day [5]. - Investors who suffered losses exceeding $75,000 between March 10, 2021, and April 15, 2025, are encouraged to contact the law firm to discuss their legal options [1].

Core Viewpoint - Semler Scientific, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act during the class period from March 10, 2021, to April 15, 2025 [3][4]. Group 1 - The class action lawsuit is based on allegations that Semler Scientific failed to disclose a material investigation by the United States Department of Justice, which is related to potential violations of the False Claims Act [3]. - The lawsuit claims that the defendants' public statements were materially false and misleading throughout the relevant time period [3]. - Shareholders who purchased shares of Semler Scientific during the specified class period are encouraged to register for the class action and may seek lead plaintiff status by the deadline of October 28, 2025 [4]. Group 2 - The Gross Law Firm, which is handling the case, is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that led to artificial inflation of stock prices [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Semler Scientific, Inc. regarding violations of federal securities laws, particularly related to undisclosed investigations by the U.S. Department of Justice [4][6]. Group 1: Legal Investigation and Claims - The firm is encouraging investors who suffered losses in Semler Scientific to contact them to discuss their legal options [1][9]. - A federal securities class action has been filed against Semler Scientific, with a deadline of October 28, 2025, for investors to seek the role of lead plaintiff [4][8]. - The complaint alleges that Semler Scientific and its executives made false or misleading statements and failed to disclose a material investigation by the DOJ into violations of the False Claims Act [6][7]. Group 2: Company Financial Impact - Following the disclosure of initial settlement discussions with the DOJ, Semler Scientific's stock fell over 9% on the next trading day [7]. - The annual report filed with the SEC indicated that the company does not believe the amount of loss from potential DOJ actions can be reasonably estimated [7]. Group 3: Firm Background - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its founding in 1995 and has offices in multiple states [5].

Core Viewpoint - Semler Scientific, Inc. is facing a securities fraud class action lawsuit due to alleged misleading statements regarding a Department of Justice investigation into the company's reimbursement claims related to the QuantaFlo device [3][5]. Group 1: Company Background and Events - On February 28, 2025, Semler disclosed in its Form 10-K that it received a civil investigative demand from the DOJ in July 2017 concerning its reimbursement claims [3]. - Following unsuccessful settlement discussions with the DOJ in February 2025, Semler's share price fell by approximately 9.39%, from $42.92 to $38.89 [3]. - On April 15, 2025, Semler announced a settlement agreement of $29.75 million to resolve all claims, leading to a further decline in share price by about 9.9%, from $34.40 to $31.00 [4]. Group 2: Lawsuit Details - The class action lawsuit is on behalf of investors who purchased Semler securities from March 10, 2021, to April 15, 2025, alleging that the company made false or misleading statements regarding the DOJ investigation [5]. - The lawsuit claims that the company failed to disclose material information about the investigation, which resulted in investor damages when the truth was revealed [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Semler Scientific, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][5]. Group 1: Class Action Details - The Class Period for the Semler Scientific securities is from March 10, 2021, to April 15, 2025 [1]. - Investors who purchased securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 28, 2025 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions of dollars for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5]. - The lawsuit claims that these misleading statements resulted in investor damages when the true details became public [5].